research-v2

SAB Members


Vivian Bykerk
Vivian Bykerk, BSc, MD, FRCP
Associate Attending Rheumatologist, Hospital for Special Surgery
Associate Professor of Medicine, Weill Cornell Medical College

Thomas Huizenga
Thomas Huizenga, MD, PhD
Chairman of the Department of Rheumatology,
Leiden University Medical Center, The Netherlands.

E-mail: T.W.J.Huizinga@lumc.nl

Professor Tom Huizinga is chairman of the Department of Rheumatology, Leiden University Medical Center, The Netherlands. Having graduated from the University of Amsterdam Medical School in 1986, Professor Huizinga went on to write his thesis, Neutrophil Fc-gamma receptors (cum laude). Following this, he studied at Dartmouth Medical School, New Hampshire, USA before returning to the Netherlands to train in internal medicine/rheumatology. This including 3 years spent at the Department of Rheumatology, Academic Hospital Leiden. Professor Huizinga qualified as an immunologist in 1991 and as a rheumatologist in 1997.

In 1997, Professor Huizinga took up the position of Rheumatologist at the Leiden University Hospital, becoming Associate Professor of Rheumatology at Leiden University in 1997 and Professor of Rheumatology at Leiden University Medical Centre in 2000. Since 2006 Professor Huizinga is chairman of the Department of Rheumatology at Leiden University Medical Centre. Professor Huizinga was a member of the Annual Meeting Planning Committee of the American College of Rheumatology from 2000 to 2003, and the Annual Meeting Planning Committee of the EULAR from 2004 to 2007. In 2006, he was appointed as a member of the Henry Kunkel Society, New York. In 2005/6 he served a member of the "Verkenningscommissie Multifactoriele Aandoeningen in het Genomics Tijdperk" of the Royal Dutch Academy of Sciences. Professor Huizinga received a number of prizes throughout his academic career, among them the “Boerhaave prize for outstanding contributions to Immunology” and has (co)authored over 500 peer-reviewed articles. His H-factor is 64. Among his grants, he received a fellowship of the Royal Academy of Arts and Sciences to study: "Regulation of TNFa-production in rheumatoid arthritis". He is member of the editorial boards of Plos Medicine, Annals of Rheumatic Diseases, Arthritis and Rheumatism, Current Rheumatology Reviews Genes and Immunity, International Journal of Advances in Rheumatology, Joint Bone Spine Revue du Rheumatism International Edition, Current Rheumatology Reviews, Clinical and Experimental Rheumatology.

Area of interest(s):

  • translational research in rheumatoid arthritis
  • clinical research in neuro-psychiatric SLE

Iain McInnes
Iain McInnes, MRCP, PhD
Professor of Experimental Medicine and Rheumatology at the University of Glasgow
Director of Glasgow Biomedical Research Center
Director of the MRC Scottish Clinical Pharmacology and Pathology Program (SCP3).
Deputy Director of the Welcome Trust Scottish Translational Medicine and Therapeutics Initiative (STMTI).

E-mail: iain.mcinnes@glasgow.ac.uk

Professor Iain McInnes studied medicine at the University of Glasgow and graduated with honours in 1989 before training in internal medicine and rheumatology. He completed his membership of the Royal College of Physicians (MRCP) in 1992 and became a fellow (FRCP) in 2003. He completed his PhD and post-doctoral studies via fellowships from the Wellcome Trust, the Arthritis Research Campaign (ARC, UK) and the National Institute of Health (NIH) Fogarty Fellowship Programme in both Glasgow and Bethesda, Maryland, USA.

Professor McInnes’ research interests include understanding the role of cytokines in inflammatory synovitis. He leads a trials unit specialising in the use of biologic agents in early clinical trials in inflammatory arthritis. Professor McInnes has published widely in the areas of immunobiology and rheumatology, and is an Associate Editor of the Annals of Rheumatic Diseases and a member of the executive Editorial Board of European Journal of Immunology. His work, together with that of his colleagues at the University of Glasgow, has been recognised in receipt of many prizes and lectureships including the Michael Mason Prize 2001 from the British Society for Rheumatology, the Albrecht Hasinger Lectureship 2002, the Nana Svartz Lectureship 2008, and the Dunlop Dotteridge Lectureship for the Canadian Rheumatology Association in 2010. He gave the BSR Droitwich Lecture in 2012, and the Gerald Weissmann Lecture in Rheumatology in New York in 2013. A previous Chairman of the EULAR Scientific Committee and ESCCA, he is now Chairman of the Scientific Committee of the European Rheumatology Research Foundation. He was elected a fellow of the Royal Society of Edinburgh in 2008 and in 2012 was elected as a Fellow of the Academy of Medical Sciences.


Robert Plenge
Robert Plenge, MD, PhD
Assistant Professor
BWH, Harvard Medical School
Research Scientist
Broad Institute of MIT and Harvard
Director, Genetics and Genomics
BWH, Division of Rheumatology, Immunology and Allergy
Boston, USA

Jane Salmon
Jane Salmon, MD
Collette Kean Research Chair
Director, SLE and APS Center of Excellence
Co-Director Kirkland Center for Lupus Research
Hospital for Special Surgery

E-mail: salmonj@hss.edu

Dr. Jane Salmon is Professor of Medicine and Professor of Obstetrics and Gynecology at Weill Cornell Medical College and the Collette Kean Research Professor at Hospital for Special Surgery.

Dr. Salmon graduated magna cum laude from New York University and earned a medical degree in 1978 from the College of Physicians and Surgeons of Columbia University, where she was the first woman enrolled in their Medical Scientist Training Program. She completed training in internal medicine at The New York Hospital and in rheumatology at Hospital for Special Surgery, and has been an HSS faculty member since 1983. Dr. Salmon has served on the Board of Directors of the American College of Rheumatology, and she is currently on the Board of Directors of the Rheumatology Research Foundation. Dr. Salmon was co-editor of Arthritis and Rheumatism and is currently an Associate Editor of Annals of Rheumatic Diseases. At Hospital for Special Surgery, she is a Director of the Lupus and APS Center of Excellence, co-Director of the Mary Kirkland Center for Lupus Research, and Director of the FOCIS Center of Excellence.

Dr. Salmon’s research has focused on elucidating mechanisms of tissue injury in lupus and other autoimmune diseases. Her basic and clinical studies have expanded our understanding of pregnancy loss and organ damage in SLE and the determinants of disease outcome in lupus patients with nephritis, pregnancy, and cardiovascular disease.

Read more